Vaccines News
-
XtalPi, CK Life Sciences announce AI-empowered tumour vaccine R&D in China
Vaccines | News | 0 Comment | 25 Nov, 2022
Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group....Read more
-
IVI, ST Pharm exchange MoU on clinical development of COVID-19 vaccine
Vaccines | News | 0 Comment | 25 Nov, 2022
The International Vaccine Institute (IVI) and ST Pharm have exchanged a Memorandum of Understanding (MoU) to establish a...Read more
-
SK bioscience announces KRW 3 Bn donation to IVI to support advancement of global vaccine R&D
Vaccines | News | 0 Comment | 18 Nov, 2022
SK bioscience, a leading vaccine manufacturer based in the Republic of Korea and a key partner of the International Vacc...Read more
-
Australia offers new nasal vaccine strategy to improve COVID-19 protection
Vaccines | News | 0 Comment | 17 Nov, 2022
Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...Read more
-
Lemonex, IVI exchange MoU on joint vaccine development in Korea
Vaccines | News | 0 Comment | 14 Nov, 2022
The International Vaccine Institute (IVI), in South Korea, has signed a memorandum of understanding (MOU) with Lemonex, ...Read more
-
CSL signs $4 B agreement with Arcturus Therapeutics for self-amplifying mRNA vaccines
Vaccines | News | 0 Comment | 04 Nov, 2022
US-based Arcturus Therapeutics Holdings Inc. has announced a strategic collaboration with CSL Seqirus, a global vaccine ...Read more
-
Hilleman, MSD to develop thermostable next-gen Zaire ebolavirus vaccine
Vaccines | News | 0 Comment | 01 Nov, 2022
Singapore-based Hilleman Laboratories has announced collaberative efforts to develop a thermostable second-generati...Read more
-
CanSino Biologics rolls out inhaled vaccine Convidecia Air in Shanghai
Vaccines | News | 0 Comment | 01 Nov, 2022
CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...Read more
-
Vaccines | Analysis | By Hithaishi C Bhaskar | 0 Comment | 31 Oct, 2022
Globally, mass vaccination practices and procedures were not pleasant experiences for everyone. Different age groups and...Read more
-
SK bioscience and Hilleman to co-develop novel vaccine platforms
Vaccines | News | 0 Comment | 27 Oct, 2022
South Korea's SK bioscience has entered a strategic partnership with Singapore based Hilleman Laboratories to co-develop...Read more
-
SK bioscience gets $140 M from CEPI to develop mRNA vaccines
Vaccines | News | 0 Comment | 26 Oct, 2022
South Korea-based SK bioscience has made a new partnership agreement with Norway-based Coalition for Epidemic Preparedne...Read more
-
LimmaTech partners with Australia's Griffith University for world’s first vaccine against gonorrhoea
Vaccines | News | 0 Comment | 25 Oct, 2022
Swiss firm LimmaTech Biologics AG has announced a license and collaboration agreement with Griffith University...Read more
-
Etana unveils biopharmaceutical factory in Indonesia
Vaccines | News | 0 Comment | 20 Oct, 2022
PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...Read more
-
Immuno Cure secures HK$8 M funding support for HIV vaccine clinical trial
Vaccines | News | 0 Comment | 18 Oct, 2022
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccin...Read more
-
EU recommends approval of Takeda's dengue vaccine
Vaccines | News | 0 Comment | 18 Oct, 2022
Japanese pharmaceutical firm Takeda has announced that the Committee for Medicinal Products for Human Use...Read more
-
We are advancing two bivalent candidates for utilisation in global vaccination efforts
Vaccines | Opinion | By Hithaishi C Bhaksar | 2 Comment | 07 Oct, 2022
Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...Read more
-
IVI announces 'vaccines partnership' with London School of Hygiene & Tropical Medicine
Vaccines | News | 0 Comment | 04 Oct, 2022
South Korea-based International Vaccine Institute (IVI) and the London School of Hygiene & Tropical Medicine (LSHTM)...Read more
-
IVI partners with Hilleman to advance vaccine R&D and manufacturing
Vaccines | News | 0 Comment | 04 Oct, 2022
South Korea-based International Vaccine Institute (IVI) has signed a three-year Memorandum of Understanding (MoU) with H...Read more
